blog

Reducing Administrative Burden for Site Staff Allows for More Time to Focus on Patients

By Jacob Silberstein, Account Executive on Wed, Oct 16, 2019 | 3 min read

 

As a former clinical research coordinator and clinic manager, I know first-hand that primary study coordinators are often the busiest members of the interdisciplinary study site teams. Managing investigator schedules, pre-screening potential participants, scheduling and confirming screening appointments, managing study drugs, and maintaining adequate staffing are just some of the myriad responsibilities a coordinator can be tasked with. And that’s not even getting to the importance of devoting your full attention to each patient in your clinic!

Topics: BBK Worldwide, Patient Engagement, Clinical Trials, Patient Experience, Patient Reimbursement, Patient Travel Programs

BBK Worldwide Makes Its Mark

By Mike Schaeffer, Creative Director - Art on Tue, Oct 8, 2019 | 4 min read

BBK Worldwide’s new logo was recently selected from among 35,000 entries to be showcased in LogoLounge Book 11 – the bestselling book series that features the leading edge of identity design by highly accomplished and noteworthy designers. The international competition was judged by a preeminent panel of experts who represent the best of the best in the design community. With this recognition, let’s take a closer look at the award-winning logo and the creative vision behind it.


Topics: BBK Worldwide, Patient Engagement, Clinical Trials, Patient Experience, Creative, Logo, Design, Brand Identity

New Partnership with Health Union Shines the Light on the Patient Voice

By BBK Worldwide on Tue, Sep 10, 2019 | 7 min read

BLOG_IMAGE

We recently had the opportunity to sit down with Lauren Lawhon, chief operating officer for Health Union, to discuss our newly formed partnership with the pioneer in online communities and how greater insight into the patient voice can enhance the clinical trial patient experience.

Topics: Patient, Patient Experience, Study Voices, Health Union

David B. Fleishman Named to PharmaVOICE 100 for His Leadership and Expertise

By BBK Worldwide on Mon, Aug 26, 2019 | 2 min read

BBK Worldwide is honorDavid_Fleishman_web copyed to announce that our Principal and Director of Accounts and Site Services, David B. Fleishman, has been named to the 2019 PharmaVOICE 100 list of the most inspiring people in the life sciences industry for representing the best of the new generation of thought leaders. The award recognizes Mr. Fleishman for how he inspires and motivates those around him, his influence as a corporate leader, and his positive impact on the industry through his actions.

Topics: Awards, Employee Recognition

With Kindness and Courtesy: RSG® Arrive Driver of the Month

By Elizabeth Gargill on Wed, Aug 14, 2019 | 3 min read

As RSG® Arrive continues to transform the clinical trial patient experience – enhancing access to care, removing barriers to participation, and fostering long-term engagement – we recognize Mike as our driver of the month. He exemplifies the qualities that set RSG® Arrive apart – dedication, commitment to care, and professionalism.

Topics: Patient Travel, Patient Experience

Moving Beyond the Myth That Doctors Won't Refer

By Elizabeth Gargill on Thu, Aug 8, 2019 | 3 min read

“Doctors won’t refer!” It’s a phrase spoken far too often – and often delivered with an air of unwavering certainty. However, growing evidence suggests otherwise – including most recently the findings from BBK Worldwide’s Study Voices survey.

Topics: BBK Worldwide, Physician Engagement, Site Support, Site Selection, Site Engagement, Clinical Trials, Study Voices

How Precision Medicine is Influencing Clinical Trials

By BBK Worldwide on Tue, Jun 4, 2019 | 1 min read

As originally conceived, personalized medicine referred to the tailoring of medical treatment to the individual characteristics of each patient. The right drug for the right patient at the right timehas since evolved to an approach that takes into account individual differences in people’s genes, environments, and lifestyles. 

Topics: Patient Experience, Pharma15 Live!, Vlog, Precision Medicine, Precision Support

AI Shows Promise in the Clinical Space for Enrollment and Adherence

By BBK Worldwide on Tue, Jun 4, 2019 | 1 min read

While most large pharma companies seem “very open” to new technologies, a recent FiercePharma article also notes that the life science industry hasn’t exactly won accolades for its speed in adopting new artificial intelligence and machine learning technologies. However, since patient lives are at stake, the industry has good reason to proceed with caution.*

Dena Raffa, Director, Account Operations and BBK’s expert in digital innovation, shares her view on the complex topic of AI and machine learning technologies in life sciences. 

Topics: Disruptive Innovation, Trends, AI, Pharma15 Live!, Vlog

BBK's Privacy Expert Shares His View on the Positive Trend in Patient Trust in Clinical Trials

By BBK Worldwide on Tue, Jun 4, 2019 | 1 min read

A recent survey shared in FiercePharma pointed to an upward trend in general public opinion of the pharmaceutical industry. But there is still work to be done.* 

Rob Laurens, Principal, Human Resources and Quality Assurance, credits much of this momentum to the work of everyone in the clinical R&D sector. 

Topics: Clinical Research, Big Data, Patient Experience, Pharma15 Live!, Vlog, Privacy

Small to Mid-Size Pharmaceutical Companies Are Meeting the Needs of a Shifting Marketplace

By Joan F. Bachenheimer on Tue, Jun 4, 2019 | 2 min read

Last year, smaller companies led in new drug approvals, according to a recent OutsourcingPharma.com article featuring Ken Getz, director of sponsored research at Tufts University. Notably, nearly half of these new drugs were for the treatment of rare diseases, demonstrating a shift within the industry away from a focus on scaling infrastructure.*

Scaling-down-Clinical-research-shifts-its-focus_wrbm_large

CEO and Founding Principal of BBK Worldwide, Joan F. Bachenheimer, responds to the article, explaining that “the precision aspects of clinical trial discovery have remapped the patient experience. The more targeted the investigational therapy, the more individualized the orientation becomes toward patient recruitment and engagement. It’s logical that the search for patients with specific biomarkers begets an orientation centered on individual needs versus a mass orientation."

Topics: Trends, Clinical Research, Rare Disease Research, Patient Experience, Precision Medicine

 
Subscribe To Our Blog